# A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

> **NCT07566390** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 48 (estimated)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** NNC0113-5840
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07566390
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2026-11-26
- **Final completion:** 2026-11-26
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07566390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07566390, "A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT07566390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*